*ST生物: 南华生物第十二届董事会第一次会议决议公告

Board Meeting Summary - The first meeting of the 12th Board of Directors of Nanhua Biopharmaceutical Co., Ltd. was held on August 8, 2025, via communication methods, with all 7 directors participating in the voting [1][2] - The board elected Mr. Yang Yun as the chairman of the 12th Board of Directors, with a term starting from the approval date until the end of the board's term [1][2] - The board approved the election of various specialized committee members, including Mr. Yang Yun as the head of the Strategy Committee [1][2] Executive Appointments - Mr. Yang Yun was appointed as the General Manager, with a term aligned with the board's term [2] - Mr. Su Liang was appointed as the Board Secretary, and Mr. Liu Ailong, along with Mr. Lin Pengbin, were appointed as Vice General Managers [2] - The board approved the adjustment of executive compensation standards and performance assessment schemes to enhance management incentives and constraints [2][3] Committee and Regulation Updates - The board approved the revision of the "Audit Committee Work Rules" to align with legal regulations and the company's actual situation [3]